Rome Therapeutics Inc

Rome Therapeutics, Inc. develops therapeutics for autoimmune diseases, cancer, and neurodegenerative diseases in the biotechnology sector. The Company utilizes data science, machine learning, and computational biology to identify drug targets within the dark genome and repetitive elements. Rome Therapeutics Inc serves patients in the United States affected by these conditions.